![Rosanne Robinson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 319 037 $ al 31/05/2026
Rosanne Elizabeth Robinson currently works at Clarity Pharmaceuticals Ltd., as Lead Independent Director from 2024, Australian Nuclear Science & Technology Organisation, as General Manager-Business Development, and Cyclotek Pty Ltd., as Chief Financial Officer.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 22/08/2025 | 178.079 ( 0,05 % ) | 319 037 $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| CLARITY PHARMACEUTICALS LTD | Director/Miembro de la Junta | 01/10/2010 |
Australian Nuclear Science & Technology Organisation | Corporate Officer/Principal | - |
Cyclotek Pty Ltd.
 Cyclotek Pty Ltd. Pharmaceuticals: MajorHealth Technology Engages in pharmaceutical and medicine manufacturing | Director Financiero/CFO | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 3 |
|---|---|
Australian Nuclear Science & Technology Organisation | |
Clarity Pharmaceuticals Ltd.
 Clarity Pharmaceuticals Ltd. Medical SpecialtiesHealth Technology Develops radiopharmaceutical products | Health Technology |
Cyclotek Pty Ltd.
Cyclotek Pty Ltd. Pharmaceuticals: MajorHealth Technology Engages in pharmaceutical and medicine manufacturing | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
